FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed AstraZeneca logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration
OTTAWA (Reuters) - Canada's drug regulator on Friday approved AstraZeneca's COVID-19 vaccine, including the version produced by the Serum Institute of India, paving the way for health authorities to accelerate Canada's lagging vaccination campaign.
The vaccines produced by AstraZeneca Plc and the Serum Institute were approved under Canada's interim order system, which allows for accelerated approvals similar to the U.S. Food and Drug Administration's emergency use authorization.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
